Coronary Bifurcation Lesion–Management

Stentys coronary bifurcation stent.

Percutaneous Coronary Intervention for Bifurcation Coronary Disease

Correspondence to: Dr Yves Louvard, Institut Cardiovasculaire Paris Sud, Institut Hospitalier Jacques Cartier, 6 avenue du Noyer Lambert, 91300 Massy, France; [email protected] _________________________ E ver since coronary angioplasty was first undertaken, treatment of coronary bifurcation lesions has posed technical problems. w2 Specific difficulties involving access to the side branch an...

Percutaneous coronary intervention of bifurcation coronary disease.

Bifurcation coronary artery disease is a frequent problem faced by interventional cardiologists and it affects approximately 15-20% of patients undergoing percutaneous coronary intervention (PCI). The application of drug-eluting stents (DES) technology to prevent restenosis after PCI represents one of the success stories in cardiology, but DES have not resolved the bifurcation PCI challenge. Bi...

Coronary Bifurcation Disease and Bifurcation Stenting: a Practical Approach

Approximately 20% of percutaneous coronary interventions (PCIs) are performed to treat coronary bifurcations. PCIs in bifurcation lesions have been associated with lower procedural success rates and worse clinical outcomes than non-bifurcation lesions. In addition, PCIs in bifurcation are renowned for being technically demanding. Indeed, there are several challenges in percutaneous treatment of...

Bifurcation coronary lesions and the "crush" technique.

aggregometry (LTA) is the most widely reported ex vivo technique to assess aspirin effect in platelets (1–3). With respect to our study potentially underestimating aspirin resistance in patients with unstable coronary syndromes, it should be noted that 23% (n 47) of our percutaneous coronary intervention (PCI) patients were in that category. All of these patients were sensitive to aspirin (4). ...